Overview of COVID-19 Vaccine Hesitancy in Low and Middle Income Countries

Authors

  • Hajra Khwaja Department of Public Health, Aga Khan University, Karachi, Pakistan
  • Sehrish Karim Department of Public Health, Aga Khan University, Karachi, Pakistan

Abstract

The unfolding of SARS CoV-2 from China and its outbreak around the world has caused chaos globally. The need to control this deadly virus led to the immediate development of the COVID vaccine, which had risen doubts among the population about its utilization. Therefore, vaccine hesitancy has major repercussions for the success of vaccine initiatives and is a threat to acquiring herd immunity; this paper discusses the level of Covid-19 vaccine hesitancy in LMICs.

 

References

WHO. Novel Coronavirus (COVID-19). Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed on 12 February 2021).

Pal M, Berhanu G, Desalegn C, Kandi V. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV2): An Update. Cureus. 2020;2. doi:10.7759/cureus.7423.

Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta bio-medica Atenei Parm. 2020;91: 157–160. doi:10.23750/abm.v91i1.93972. Liu, J.; Liao, X.; Qian, S.; Yuan, J.; Wang, F.; Liu, Y.; Wang, Z.; Wang, F.-S.; Liu, L.; Zhang, Z. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg. Infect. Dis. 2020, 26, 1320.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020 Mar 28;395(10229):1054-62.

Stadnytskyi V, Bax CE, Bax A, Anfinrud P. The airborne lifetime of small speech droplets and their potential importance in SARS- CoV-2 transmission. Proceedings of the National Academy of Sciences. 2020 Jun 2;117(22):11875-7.

Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England journal of medicine. 2020 Apr 16;382(16):1564-7.

Xiao F, Sun J, Xu Y, Li F, Huang X, Li H, Zhao J, Huang J, Zhao J. Infectious SARS-CoV-2 in feces of patient with severe COVID- 19. Emerging infectious diseases. 2020 Aug;26(8):1920.

Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in different types of clinical specimens. Jama. 2020 May 12;323(18):1843-4.

Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G. First case of 2019 novel coronavirus in the United States. New England journal of medicine. 2020 Jan 31.

Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, Park JH, Na HK, Oh MD. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. Journal of Korean medical science. 2020 Feb 10;35(5).

Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, Nguyen TT, Cao TM, Pham QD. Importation and human-to- human transmission of a novel coronavirus in Vietnam. New England Journal of Medicine. 2020 Feb 27;382(9):872-4.

Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, Seilmaier M. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England journal of medicine. 2020 Mar 5;382(10):970-1.

Gilbert M, Pullano G, Pinotti F, Valdano E, Poletto C, Boëlle PY, d'Ortenzio E, Yazdanpanah Y, Eholie SP, Altmann M, Gutierrez B. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study. The Lancet. 2020 Mar 14;395(10227):871-7.

https://www.ndtv.com/world-news/nepal-reports-south-asias-first-confirmed-case-of-deadly-coronavirus-2169362.

Shrestha R, Shrestha S, Khanal P, Kc B. Nepal’s first case of COVID-19 and public health response. Journal of travel medicine. 2020 Apr;27(3):taaa024.

Javed N, Khawaja H, Malik J, Ahmed Z. Endocrine dysfunction in psychology during social distancing measures. Bratislavske Lekarske Listy. 2020 Jan 1;121(12):878-80.

https://www.who.int/ith/ITH-Chapter6.pdf

AgrawalA,KolhapureS,DiPasqualeA,RaiJ,MathurA.VaccineHesitancyasachallengeorvaccineconfidenceasanopportunity for childhood immunisation in India. Infectious diseases and therapy. 2020 Sep;9(3):421-32.

https://www.medrxiv.org/content/10.1101/2021.03.11.21253419v1.

World Health Organization. Draft landscape of COVID-19 candidate vaccines. [Accessed January 20, 2021]. https://www.who.int/publications/m/item/draftlandscape-of-covid-19-candidate-vaccines.

Skeete JP. Level 5 autonomy: The new face of disruption in road transport. Technological Forecasting and Social Change. 2018 Sep 1;134:22-34.

Banik R, Rahman M, Sikder M, Rahman QM, Pranta MU. Knowledge, attitudes, and practices related to the COVID-19 pandemic among Bangladeshi youth: a web-based cross-sectional analysis. Journal of Public Health. 2021 Jan 16:1-1.

Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK. & Mudatsir, M.(2020). Acceptance of a COVID-19 vaccine in southeast Asia: A cross-sectional study in Indonesia. Frontiers in public health.;8.

Perveen S, Akram M, Nasar A, Arshad‐Ayaz A, Naseem A. Vaccination‐hesitancy and vaccination‐inequality as challenges in Pakistan's COVID‐19 response. Journal of community psychology. 2022 Mar;50(2):666-83.

Razai MS, Chaudhry UA, Doerholt K, Bauld L, Majeed A. Covid-19 vaccination hesitancy. Bmj. 2021 May 20;373.

Boyon N. Global attitudes on a covid vaccine. 2020.

Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020 Sep 1;26:100495.

SvenssonJ.COVI19VaccineAcceptanceandHesitancyinLowandMiddleIncomeCountries,andImplicationsforMessaging. Nature Medicine. 2021;27:1385-94.

Nzaji MK, Ngombe LK, Mwamba GN, Ndala DB, Miema JM, Lungoyo CL, Mwimba BL, Bene AC, Musenga EM. Acceptability of vaccination against COVID-19 among healthcare workers in the Democratic Republic of the Congo. Pragmatic and observational research. 2020;11:103.

IOL. 52% of South Africans Don’t Want Covid Vaccine, Despite SA Securing Initial Batch. Available online: https: //www.iol.co.za/personal-finance/insurance/52-of-south-africans-dont- want-covid- vaccine-despite- sa-securing- initial- batch- f45373f0-6199-46ab-8207-fb632706b8e5.

Tozivepi SN, Mundagowa P, Tirivavi M, Maponga B, Mugwagwa N, Magande P, Mutseyekwa F, Makurumidze R. Covid-19 Vaccine Hesistancy Survey Preliminary Report. Zimbabwe College of Public Health Physicians: Harare, Zimbabwe. 2020.

Ghazi H, Taher T, Alfadhul S, Al-Mahmood S, Hassan S, Hamoudi T, Raheema R. Acceptance Of Covid-19 Vaccine Among General Population In Iraq: Acceptance Of Covid-19 Vaccine Among General Population In Iraq. Iraqi National Journal of Medicine. 2021 Dec 6;3(1):93-103.

Alabdulla M, Reagu SM, Al‐Khal A, Elzain M, Jones RM. COVID‐19 vaccine hesitancy and attitudes in Qatar: A national cross‐ sectional survey of a migrant‐majority population. Influenza and other respiratory viruses. 2021 May;15(3):361-70.

AliM,HossainA.WhatistheextentofCOVID-19vaccinehesitancyinBangladesh?Across-sectionalrapidnationalsurvey.BMJ open. 2021 Aug 1;11(8):e050303.

Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Frontiers in public health. 2020 Jul 14;8:381.

Ditekemena JD, Nkamba DM, Mutwadi A, Mavoko HM, Siewe Fodjo JN, Luhata C, Obimpeh M, Van Hees S, Nachega JB, Colebunders R. COVID-19 vaccine acceptance in the Democratic Republic of Congo: a cross-sectional survey. Vaccines. 2021 Feb 14;9(2).

Nzaji MK, Ngombe LK, Mwamba GN, Ndala DB, Miema JM, Lungoyo CL, Mwimba BL, Bene AC, Musenga EM. Acceptability of vaccination against COVID-19 among healthcare workers in the Democratic Republic of the Congo. Pragmatic and observational research. 2020;11:103.

Baden Lindsey R, El Sahly Hana M, Essink Brandon KK, Frey Sharon NR, Diemert David SS, Rouphael Nadine CB, McGettigan John KS. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403-16.

Thomas SJ, Moreira Jr ED, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Polack FP, Zerbini C, Bailey R. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. New England Journal of Medicine. 2021 Nov 4;385(19):1761-73.

Downloads

Published

2022-12-30

How to Cite

Khwaja, H. ., & Karim, S. (2022). Overview of COVID-19 Vaccine Hesitancy in Low and Middle Income Countries. ALTAMASH JOURNAL OF DENTISTRY AND MEDICINE, 1(2), 78–83. Retrieved from https://ajdm.altamash.edu.pk/index.php/ojs3/article/view/13

Issue

Vol. 1 No. 2 (2022): Altamash Journal of Dentistry and Medicine

Section

Short Communication

License

Copyright (c) 2022 ALTAMASH JOURNAL OF DENTISTRY AND MEDICINE

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Altamash Journal of Dentistry and Medicine is an open-access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0